My Nigerian Share Picks for the first quarter of 2025
In this video, I analyzed my share picks from September - the last quarter of 2024 and found by analysis an over 50% increment in portfolio. If you want to have my share picks for first quarter of 2025. Please visit tally.so/r/nWYqbv
Breakdown for the last quarter of 2024; Average % Change: About +54.53% across 19 shares
Largest Gain: SUNUASS with +597.67%.
Largest Decline: DAARCOM with –11.27%.
Stocks with Notable Increases
SUNUASS (+597.67%) is an extreme outlier, far exceeding other gains.
Several others also showed strong growth, notably:
#UBA (+48.29%)
#STERLING (+47.06%)
#NEM (+44.74%)
ETI (+33.97%)
ROYALEX (+30.77%)
FTNCOCO (+30.43%)
Stocks with Moderate Increases
VITAFOAM (+36.57%), WEMABA (+40.31%), JAIZBANK (+38.89%), ACCESSC (+26.91%), FBNH (+27.73%), and UPDC (+23.85%) also contributed significantly to the overall positive trend.
Stocks with Declines
Only three recorded losses:
DAARCOM (–11.27%)
CHAMS (–5.85%)
NASCON (–8.82%)
The declines were relatively small compared to the large gains seen elsewhere. Overall, this set of shares leans strongly positive, with a few exceptions.
Breakdown for the last quarter of 2024; Average % Change: About +54.53% across 19 shares
Largest Gain: SUNUASS with +597.67%.
Largest Decline: DAARCOM with –11.27%.
Stocks with Notable Increases
SUNUASS (+597.67%) is an extreme outlier, far exceeding other gains.
Several others also showed strong growth, notably:
#UBA (+48.29%)
#STERLING (+47.06%)
#NEM (+44.74%)
ETI (+33.97%)ROYALEX (+30.77%)FTNCOCO (+30.43%)
Stocks with Moderate Increases
VITAFOAM (+36.57%), WEMABA (+40.31%), JAIZBANK (+38.89%), ACCESSC (+26.91%), FBNH (+27.73%), and UPDC (+23.85%) also contributed significantly to the overall positive trend.
Stocks with Declines
Only three recorded losses:
DAARCOM (–11.27%)
CHAMS (–5.85%)
NASCON (–8.82%)
The declines were relatively small compared to the large gains seen elsewhere. Overall, this set of shares leans strongly positive, with a few exceptions.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.